Budget 2026: Ibrutinib, Venetoclax, Ribociclib Now Duty-Free, Cancer Drugs Cheaper for Patients
New Delhi: The Union Budget 2026-27 signals one of the most comprehensive expansions of India's healthcare vision in recent years, combining higher public spending, pharmaceutical industrial strategy, regulatory strengthening, and…